Isoindolone derivatives as MEK kinase inhibitors and methods of use

Details for Australian Patent Application No. 2009266953 (hide)

Owner GENENTECH, INC.

Inventors Jackson, Philip; Heald, Robert Andrew; Gancia, Emanuela; Price, Stephen

Agent Griffith Hack

Pub. Number AU-A-2009266953

PCT Pub. Number WO2010/003022

Priority 61/077,432 01.07.08 US

Filing date 1 July 2009

Wipo publication date 7 January 2010

International Classifications

C07D 209/44 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4035 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2010/003022 Priority application(s): WO2010/003022

27 January 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 15 Dec 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009266956-Bicyclic heterocycles as MEK kinase inhibitors

2009266952-Charging stations for electric vehicles